The Asia Pacific Interventional Oncology Market would witness market growth of 6.7% CAGR during the forecast period (2022-2028).
One of the newest and most promising applications of IO is the precise delivery of innovative therapeutic medicines into tumours through catheter or direct intratumoral injection. Guided imaging had also been utilized to deploy cancer-killing viral and bacterial treatments. IO is also employed to guide tumour ablation, especially in patients with liver cancer. The imaging modality cone-beam computed tomography (CBCT) delivers more information than typical 2D imaging. Around the patient, a rotating C-arm including an X-ray source and a flat panel detector is used in CBCT.
As targeted therapy and oncology advance, it's more important than ever to collect frequent tissue so that doctors can learn about each cancer's unique genetic and immunological characteristics. As the present biopsy approach already involves numerous cores, specimens are treated in several ways for different studies, ranging from genomic to protein biomarker to fluorescence in situ hybridization, and specimens are handled in multiple ways for different analyses. Even though most biopsy planning depends on anatomic imaging, IO could utilize molecular imaging to assist lead the practitioner to select high-interest lesions. Oncologists can now examine the molecular data of cancer's most active locations, allowing for more accurately focused treatment.
The National Health and Family Planning Commission (NHFPC) that the health budget for 2016 is 1.24 trillion yuan, with the average annual growth rate of medical input above 20% over the past seven years. The eventual aim of healthcare reform, according to the commission, is to create a national health security system that focuses on providing everyone with equitable access to fundamental public health services. The budget is also utilized to encourage public hospital reform and upgrades at or above the county level. As per the NHFPC, the central government would give each county 3 million yuan per year to achieve the target, while paying a lump-sum of 20 million yuan to each city.
China is likewise working to reduce the financial burden on the poor. As per the NHFPC and the State Council's Leading Group Office of Poverty Alleviation and Development, by 2013, 12.56 million people were living in poverty due to costly medical expenditures, representing for 42.4 percent of the overall poor. Due to this high spending over medical and healthcare infrastructure across this region, the growth of the regional interventional oncology market would surge over the forecast period.
The China market dominated the Asia Pacific Interventional Oncology Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $231 million by 2028. The Japan market is poised to grow at a CAGR of 6% during (2022 - 2028). Additionally, The India market would display a CAGR of 7.3% during (2022 - 2028).
Based on Cancer Type, the market is segmented into Liver Cancer, Lung Cancer, Kidney Cancer, Breast Cancer, Prostate Cancer, Bone Metastasis, and Others. Based on Product Type, the market is segmented into Embolization Devices, Ablation Devices, and Support Devices. Based on End User, the market is segmented into Hospitals, Ambulatory Surgery Centers, and Research & Academic Institutes. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Interventional Oncology Market is Projected to reach USD 2.9 Billion by 2028, at a CAGR of 6.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Teleflex, Inc., Cook Medical, Inc. (Cook Group), Medtronic PLC, Terumo Corporation , Johnson & Johnson (Johnson & Johnson Services, Inc.), Becton, Dickinson and Company, AngioDynamics, Inc., Merit Medical Systems, Inc., and HealthTronics, Inc. (Altaris Capital Partners, LLC)
Scope of the Study
Market Segments Covered in the Report:
By Cancer Type
- Liver Cancer
- Lung Cancer
- Kidney Cancer
- Breast Cancer
- Prostate Cancer
- Bone Metastasis
- Others
By Product Type
- Embolization Devices
- Ablation Devices
- Support Devices
By End User
- Hospitals
- Ambulatory Surgery Centers
- Research & Academic Institutes
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Boston Scientific Corporation
- Teleflex, Inc.
- Cook Medical, Inc. (Cook Group)
- Medtronic PLC
- Terumo Corporation
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Becton, Dickinson and Company
- AngioDynamics, Inc.
- Merit Medical Systems, Inc.
- HealthTronics, Inc. (Altaris Capital Partners, LLC)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Interventional Oncology Market, by Cancer Type
1.4.2 Asia Pacific Interventional Oncology Market, by Product Type
1.4.3 Asia Pacific Interventional Oncology Market, by End User
1.4.4 Asia Pacific Interventional Oncology Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Interventional Oncology Market by Cancer Type
3.1 Asia Pacific Liver Cancer Market by Country
3.2 Asia Pacific Lung Cancer Market by Country
3.3 Asia Pacific Kidney Cancer Market by Country
3.4 Asia Pacific Breast Cancer Market by Country
3.5 Asia Pacific Prostate Cancer Market by Country
3.6 Asia Pacific Bone Metastasis Market by Country
3.7 Asia Pacific Others Market by Country
Chapter 4. Asia Pacific Interventional Oncology Market by Product Type
4.1 Asia Pacific Embolization Devices Market by Country
4.2 Asia Pacific Ablation Devices Market by Country
4.3 Asia Pacific Support Devices Market by Country
Chapter 5. Asia Pacific Interventional Oncology Market by End User
5.1 Asia Pacific Hospitals Market by Country
5.2 Asia Pacific Ambulatory Surgery Centers Market by Country
5.3 Asia Pacific Research & Academic Institutes Market by Country
Chapter 6. Asia Pacific Interventional Oncology Market by Country
6.1 China Interventional Oncology Market
6.1.1 China Interventional Oncology Market by Cancer Type
6.1.2 China Interventional Oncology Market by Product Type
6.1.3 China Interventional Oncology Market by End User
6.2 Japan Interventional Oncology Market
6.2.1 Japan Interventional Oncology Market by Cancer Type
6.2.2 Japan Interventional Oncology Market by Product Type
6.2.3 Japan Interventional Oncology Market by End User
6.3 India Interventional Oncology Market
6.3.1 India Interventional Oncology Market by Cancer Type
6.3.2 India Interventional Oncology Market by Product Type
6.3.3 India Interventional Oncology Market by End User
6.4 South Korea Interventional Oncology Market
6.4.1 South Korea Interventional Oncology Market by Cancer Type
6.4.2 South Korea Interventional Oncology Market by Product Type
6.4.3 South Korea Interventional Oncology Market by End User
6.5 Singapore Interventional Oncology Market
6.5.1 Singapore Interventional Oncology Market by Cancer Type
6.5.2 Singapore Interventional Oncology Market by Product Type
6.5.3 Singapore Interventional Oncology Market by End User
6.6 Malaysia Interventional Oncology Market
6.6.1 Malaysia Interventional Oncology Market by Cancer Type
6.6.2 Malaysia Interventional Oncology Market by Product Type
6.6.3 Malaysia Interventional Oncology Market by End User
6.7 Rest of Asia Pacific Interventional Oncology Market
6.7.1 Rest of Asia Pacific Interventional Oncology Market by Cancer Type
6.7.2 Rest of Asia Pacific Interventional Oncology Market by Product Type
6.7.3 Rest of Asia Pacific Interventional Oncology Market by End User
Chapter 7. Company Profiles
7.1 Boston Scientific Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Teleflex, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Cook Medical, Inc. (Cook Group)
7.3.1 Company Overview
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent Strategies and Developments
7.4.5.1 Product Launches and Product Expansions:
7.4.6 SWOT Analysis
7.5 Terumo Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Regional Analysis
7.5.5 Recent Strategies and Developments
7.5.5.1 Partnerships, Collaborations and Agreements:
7.5.5.2 Acquisitions and Mergers:
7.6 Johnson & Johnson (Johnson & Johnson Services, Inc.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental &Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Becton, Dickinson and Company
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 SWOT Analysis
7.8 AngioDynamics, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expenses
7.9 Merit Medical Systems, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.10. HealthTronics, Inc. (Altaris Capital Partners, LLC)
7.10.1 Company Overview
TABLE 1 Asia Pacific Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Liver Cancer Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Liver Cancer Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Lung Cancer Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Lung Cancer Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Kidney Cancer Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Kidney Cancer Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Breast Cancer Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Breast Cancer Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Prostate Cancer Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Prostate Cancer Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Bone Metastasis Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Bone Metastasis Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Embolization Devices Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Embolization Devices Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Ablation Devices Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Ablation Devices Market by Country, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Support Devices Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Support Devices Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 29 Asia Pacific Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 30 Asia Pacific Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 31 Asia Pacific Ambulatory Surgery Centers Market by Country, 2018 - 2021, USD Million
TABLE 32 Asia Pacific Ambulatory Surgery Centers Market by Country, 2022 - 2028, USD Million
TABLE 33 Asia Pacific Research & Academic Institutes Market by Country, 2018 - 2021, USD Million
TABLE 34 Asia Pacific Research & Academic Institutes Market by Country, 2022 - 2028, USD Million
TABLE 35 Asia Pacific Interventional Oncology Market by Country, 2018 - 2021, USD Million
TABLE 36 Asia Pacific Interventional Oncology Market by Country, 2022 - 2028, USD Million
TABLE 37 China Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 38 China Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 39 China Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 40 China Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 41 China Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 42 China Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 43 China Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 44 China Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 45 Japan Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 46 Japan Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 47 Japan Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 48 Japan Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 49 Japan Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 50 Japan Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 51 Japan Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 52 Japan Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 53 India Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 54 India Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 55 India Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 56 India Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 57 India Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 58 India Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 59 India Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 60 India Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 61 South Korea Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 62 South Korea Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 63 South Korea Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 64 South Korea Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 65 South Korea Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 66 South Korea Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 67 South Korea Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 68 South Korea Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 69 Singapore Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 70 Singapore Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 71 Singapore Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 72 Singapore Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 73 Singapore Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 74 Singapore Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 75 Singapore Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 76 Singapore Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 77 Malaysia Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 78 Malaysia Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 79 Malaysia Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 80 Malaysia Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 81 Malaysia Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 82 Malaysia Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 83 Malaysia Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 84 Malaysia Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 85 Rest of Asia Pacific Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 86 Rest of Asia Pacific Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 87 Rest of Asia Pacific Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 88 Rest of Asia Pacific Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 89 Rest of Asia Pacific Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 90 Rest of Asia Pacific Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 91 Rest of Asia Pacific Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 92 Rest of Asia Pacific Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 93 key Information – Boston Scientific Corporation
TABLE 94 key Information – Teleflex, Inc.
TABLE 95 key Information – Cook Medical, Inc.
TABLE 96 Key Information – Medtronic PLC
TABLE 97 Key Information – Terumo Corporation
TABLE 98 Key information – Johnson & Johnson
TABLE 99 Key information – Becton, Dickinson and Company
TABLE 100 Key Information – AngioDynamics, Inc.
TABLE 101 Key Information – Merit Medical Systems, Inc.
TABLE 102 Key Information – HealthTronics, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 SWOT Analysis: Boston Scientific Corporation
FIG 3 Swot analysis: Medtronic plc
FIG 4 SWOT analysis: Johnson & Johnson
FIG 5 Swot analysis: Becton, Dickinson and company